Showing results (1-10 of 190) with videos related to
Sort By:
Pageof 19
Current Opinion in Genetics & Development|April 3, 2010
Epimutations and cancer predisposition: importance and mechanismsLuke B Hesson, Megan P Hitchins, Robyn L WardMethods in Molecular Biology (Clifton, N.J.)|May 15, 2014
Discrimination of pseudogene and parental gene DNA methylation using allelic bisulfite sequencingLuke B Hesson, Robyn L WardCancer Prevention Research (Philadelphia, Pa.)|October 1, 2009
Favoritism in DNA methylationMegan P Hitchins, Robyn L WardEpigenetics|April 11, 2014
The evidence for functional non-CpG methylation in mammalian cellsVibha Patil, Robyn L Ward, Luke B HessonEpigenomics|September 25, 2013
Establishing the clinical utility of epigenetic markers in cancer: many challenges aheadPeter Zarzour, Luke B Hesson, Robyn L WardClinical Epigenetics|April 21, 2016
Defining the criteria for identifying constitutional epimutationsMathew A Sloane, Robyn L Ward, Luke B HessonFamilial Cancer|January 12, 2010
Detection of allelic imbalance in MLH1 expression by pyrosequencing serves as a tool for the identification of germline defects in Lynch syndromeChau-To Kwok, Robyn L Ward, Nicholas J Hawkins, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 25, 2010
Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancerJustin J-L Wong, Nicholas J Hawkins, Robyn L Ward, et al.Biological Procedures Online|April 12, 2012
A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell linesLuke B Hesson, Deborah Packham, Emily Pontzer, et al.Human Mutation|February 19, 2016
Understanding the Pathogenicity of Noncoding Mismatch Repair Gene Promoter Variants in Lynch SyndromeQing Liu, Bryony A Thompson, Robyn L Ward, et al.Pageof 19